ECDC CORPORATE Annual Report of the Director 2016 www.ecdc.europa.eu ECDC CORPORATE Annual report of the Director 2016 Suggested citation: European Centre for Disease Prevention and Control. Annual report of the Director, 2016. Stockholm: ECDC; 2017. Stockholm, July 2017 ISBN 978-92-9498-075-5 ISSN 1977-0081 doi 10.2900/565270 Catalogue number TQ-AB-17-001-EN-N © European Centre for Disease Prevention and Control, 2017 Reproduction is authorised, provided the source is acknowledged ii ECDC CORPORATE Annual Report of the Director 2016 Contents Abbreviations ................................................................................................................................................ v Foreword by the Chair of the Management Board ............................................................................................. 7 Introduction by the Director ............................................................................................................................ 8 Executive summary ........................................................................................................................................ 9 Part I. Policy achievements .................................................................................................................... 13 1. Surveillance and epidemic intelligence ........................................................................................................ 13 1.1 Surveillance ...................................................................................................................................... 13 1.2 Epidemic intelligence ......................................................................................................................... 14 2. Scientific support ..................................................................................................................................... 15 2.1 Scientific advice ................................................................................................................................ 15 2.2 Microbiology ..................................................................................................................................... 16 3. Preparedness and response ...................................................................................................................... 18 3.1 EU and country preparedness support ................................................................................................. 18 3.2 Response and emergency operations .................................................................................................. 19 4. Training and capacity building ................................................................................................................... 20 4.1 Public health training ......................................................................................................................... 20 4.2 International relations ....................................................................................................................... 21 5. Communication ........................................................................................................................................ 22 5.1 Health communication ....................................................................................................................... 22 5.2 Eurosurveillance ................................................................................................................................ 23 6. Disease Programmes ................................................................................................................................ 24 6.1 Antimicrobial resistance and healthcare-associated infections ................................................................ 24 6.2 Emerging and vector-borne diseases ................................................................................................... 25 6.3 Food- and waterborne diseases and Legionnaires’ disease .................................................................... 26 6.4 HIV, sexually transmitted infections and viral hepatitis .......................................................................... 27 6.5 Influenza and other respiratory viruses ............................................................................................... 28 6.6 Tuberculosis ..................................................................................................................................... 29 6.7 Vaccine-preventable diseases ............................................................................................................. 30 7. Management ........................................................................................................................................... 31 7.1 General management ........................................................................................................................ 31 7.2 Collaboration and cooperation with EU institutions and Member States .................................................. 32 7.3 Resource management and organisational development ....................................................................... 33 7.4 Information and communication technologies ...................................................................................... 34 Part II (a). Management ......................................................................................................................... 36 1 Management Board ................................................................................................................................... 36 2 Major events............................................................................................................................................. 36 3 Budgetary and financial management ......................................................................................................... 38 4 Human resources management .................................................................................................................. 38 5 Assessment by management ...................................................................................................................... 39 6 Budget implementation tasks entrusted to other services and entities ............................................................ 40 7 Assessment of audit results during the reporting year................................................................................... 40 8 Follow-up of recommendations and action plans for audits ........................................................................... 41 9 Follow-up of observations from the discharge authority ................................................................................ 41 Part II (b). External evaluations ............................................................................................................ 43 External evaluation ...................................................................................................................................... 43 Internal evaluations ..................................................................................................................................... 43 Annual stakeholder surveys .......................................................................................................................... 44 Part III. Assessment of the effectiveness of the internal control systems ........................................... 45 1 Risk management ..................................................................................................................................... 45 2 Compliance and effectiveness of internal control standards ........................................................................... 47 Part IV. Management assurance ............................................................................................................ 48 1 Review of the elements supporting assurance .............................................................................................. 48 2 Reservations ............................................................................................................................................. 48 3 Overall conclusions on assurance ................................................................................................................ 48 Part V. Declaration of assurance ............................................................................................................ 49 iii Annual Report of the Director 2016 ECDC CORPORATE Annexes ................................................................................................................................................... 51 Annex Ia. Results 2016 of the SMAP/annual programme indicators ................................................................... 51 Annex Ib. Implementation of the Work Programme 2016 ................................................................................ 57 Annex II. Statistics on financial management ................................................................................................. 65 Annex III. Organisational chart ..................................................................................................................... 65 Annex IV. Establishment plan ........................................................................................................................ 66 Annex V.